OBJECTIVE:To put forward some suggestions for the development of e-commerce in China's pharmaceutical retail chains.METHODS:To drawn on experiences from the western developed countries in developing B to C pharmaceutical e-commerce and analyzed the problems existing in China's pharmaceutical industry.RESULTS & CONCLUSIONS:To develop e-commerce in China's pharmaceutical retail chains,the cooperated supervision of the concerned governmental departments is indispensable,in addition,the level of informatization should be improved step by step and the network of retail chain should be relied on to offer customer-centered services.

OBJECTIVE: To propose some suggestions towards the operation and development of online pharmacies in China.METHODS: From the following three aspects: website design,information provision,and customer service,the paper introduced and compared the websites of three approved online pharmacies,which include Jingwei Pharmacy,Shanghai Pharmacy and Jinxiang Pharmacy.RESULTS & CONCLUSIONS: To develop online pharmacies,the information display should be customer-centered,new marketing plans based on the characteristics of the internet should be developed;meanwhile,the operators of online pharmacies should help consumers developing an awareness of drug safety and offer them corresponding services.

OBJECTIVE:To evaluate the performance of merger and acquisition (M&A) of listed pharmaceutical companies over 3 years from 2000 to 2002. METHODS: Based on the financial data of the listed companies in 26 cases, a data envelopment analysis was performed to compare and evaluate the efficiency of the companies before and after M&A. RESULTS: The efficiency was reduced in the first 3 years after M&A, but increased started from the fourth year. CONCLUSIONS: M&A did not promote the efficiency of listed pharmaceutical companies.

Adolescent ; Adult ; Cholecystitis ; complications ; drug therapy ; surgery ; Cholecystolithiasis ; complications ; drug therapy ; surgery ; Drugs, Chinese Herbal ; therapeutic use ; Female ; Humans ; Male ; Middle Aged ; Pancreatitis ; drug therapy ; etiology ; surgery ; Phytotherapy ; Postoperative Period ; Sphincterotomy, Endoscopic

OBJECTIVE:To provide references for the diversified development of chain drugstore.METHODS:The man?agement characteristics and the development tendency of chain drugstore were analyzed by using5competitive forces model together with examples.RESULTS&CONCLUSIONS:Chain drugstore should adhere to a long-term development,sparing no efforts to seek a road of development characteristic of their own and try to diversify its management forms,range of com?modities,services and brands,and standardize its administration,etc.

OBJECTIVE:To evaluate the subsequent performance after the merger & acquisition (M&A) in the form of cash in medical industry during 3 years from 2000 to 2002.METHODS:Base on the financial data of the merging party and by means of principal component analysis and factor analysis,a scoring system was built for the evaluation of the performance of M&A so that the comparison of effect scores before and after M&A could be realized.RESULTS:The effect scores fluctuate dramatically after M&A,but finally reverted to the initial level before M&A.CONCLUSION:M&A in the form of cash failed to bring long-term profits to the entire medical industry.

Objective: This study aims to analyze the outpatient prescriptions in primary rural health institutions in western China to reveal the feature and disadvantages of utilization of Chinese patent medicines in rural areas.Methods: A total of 14336 prescriptions were selected from 132 health institutions in rural areas of 7 provinces in western China in 2011.The utilization of Chinese patent medicines is described and compared to the health institutions in different levels and different provinces/autonomous regions.Results: The prescriptions of Chinese patent medicines accounted for 62.47% of the total prescriptions in rural health facilities.The proportion of county, township and village medical institutions was 49.76%, 56.96% and 71.51% respectively.86.84% of the Chinese patent medicines prescriptions were prescribed by physicians without traditional Chinese medicine background, while only 13.16% of them were traditional Chinese medicine physicians.The number of varieties of Chinese patent medicines in a single prescription in county, township and village health institutions were 1.38, 1.91 and 2.54, respectively and the average drug costs of every prescription in these health institutions were 52.20 yuan, 21.89 yuan and 19.37 yuan, respectively.Conclusions: There are differences in the utilization of Chinese patent medicines in outpatient prescriptions of rural health institutions in western China.The hospitals in higher medical level use more Chinese patent medicines.The drug cost of the prescription of county health institutions is higher than that of township and village hospitals.This study suggests that health policy should be adjusted based on the specific needs and characteristics of rural health institutions at a different level and should be implemented in the management of prescription in quality control.

Objective The objective of this paper is to statistically analyze what influence can the utilization of Traditional Chinese Medicine (TCM) have on healthcare expenses of inpatients, and to investigate whether TCM has an advantage of reducing healthcare expenses among certain diseases.Method: Inpatient medical records from 13 public general hospitals in Ningxia Hui autonomous region were collected to set up a database.A multiple linear regression models was established and used to analyze the impact of using TCM on hospitalization expenses.Results: The findings have shown that inpatients who apply TCM have significantly higher hospitalization expenses, with an estimated average of ?8 276.24, while those who do not apply TCM in their treatment spend ?7 254.59 on average (P=0.000).When the proportion of TCM expense higher than 10% of total drug expense, inpatients who apply the TCM have lower hospitalization expenses.In addition, hospitalization expenses decrease with the increase of TCM proportion.Among the diseases of the ear and mastoid disease, diseases of the circulatory system, and certain conditions originating in the perinatal period, inpatients who apply TCM have significant lower hospitalization expense (P=0.000).Hospitalization expense of inpatients who do not apply TCM is twice as much as that of those who apply TCM in the treatment of among diseases of the circulatory system, which has the largest TCM proportion.Conclusion: Only when applying TCM as main therapy can provide price advantage of TCM in the circulatory system caused by chronic diseases, and other advantages of treatment.

OBJECTIVE:To find out potential financial risk in the listed Chinese pharmaceutical companies and to provide rec-ommendations. METHODS:The Z-score established with Altman E was adopted to classiy and analyzed empirically 143 listed phar-maceutical companies in China during 1998-2013 by sub-sectors(medical devices,pharmaceutical commercial,biological products chemical raw medicine,traditional TCM). The effects of some data in annual reports on Z-score were validated by using stepwise regression. RESULTS:The result showed that the average Z-score values percentage of the best 3 companies were 90.95%,47.96%and 41.25%,respectively,from 1998-2013;while for the worst 3 companies,the values were 0.80%,1.14%and 1.21%,respective-ly. At the same time,the financial situations of chemical raw medicine companies were the worst among 5 sub-sectors,of which dur-ing 2004-2006,the constituent ratios of companies in“Distress”zones went over 50.00%,which were 60.00%,55.20% and 53.60%,respectively. If counted by calendar year,the market value per share of 10 years and float of 9 years significantly affected the Z-score values(P<0.05);if counted by listed year,the market value per share of 15 years significantly affected the Z-score val-ues. CONCLUSIONS:Although major pharmaceutical companies have good financial status,financial crisis still exists in some companies. Especially,the financial situations of chemical raw medicine companies should not be neglected. The government should pay more attention to share price in order to prevent financial crisis which was induced by stock bubbles;at the same time,supervi-sion system should be established to evaluate the financial situation of listed pharmaceutical companies,even for all listed companies.

Objective To evaluate the criteria for diagnosis of atypical squamous cells(ASC)and its two subtypes: undetermined significance ASC (ASC US) and atypical squamous cells cannot exclude high grade intraepithelial lesion (HSIL, ASC H) defined in 2001 the Bethesda system(TBS) Method One thousand one hundred and eighty six pap smears and liquid based thin layer preparations with diagnosis of atypical squamous cells of undetermined signification (ASCUS) according to TBS 1991 criteria, were re classified by a cytopathologist using TBS 2001 criteria Results The cytologic diagnosis according to TBS 2001 criteria was: negative in 285 cases(24 0 %), ASC US in 627 cases (52 9 %), ASC H in 254 cases(21 4 %), low grade intraepithelial lesion (LISL) in 16 cases(1 3 %), and HISL in 4 cases (0 3 %), respectively Out of 1186 cases, 168 received histological examination Cervical intra epithelial neoplasia (CIN) II III were diagnosed in 18 9 % of patients with ASC H, 5 2% of patients with ASC US, and 14 3% of patients with ASCUS defined by using TBS 1991 criteria, respectively ( P